The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(2R)-2-{[6-ethyl-5-(3-hydroxyphenyl)thieno[2,3-d]pyrimidin-4-yl]amino}propanoic acid ID: ALA4521112
PubChem CID: 155542475
Max Phase: Preclinical
Molecular Formula: C17H17N3O3S
Molecular Weight: 343.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1sc2ncnc(N[C@H](C)C(=O)O)c2c1-c1cccc(O)c1
Standard InChI: InChI=1S/C17H17N3O3S/c1-3-12-13(10-5-4-6-11(21)7-10)14-15(20-9(2)17(22)23)18-8-19-16(14)24-12/h4-9,21H,3H2,1-2H3,(H,22,23)(H,18,19,20)/t9-/m1/s1
Standard InChI Key: ZVAJPNVZGQNWQE-SECBINFHSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
4.4865 -12.4418 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4853 -13.2613 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1934 -13.6703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.9005 -13.2568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9002 -12.4382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1916 -12.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1891 -11.2158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4802 -10.8093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7737 -11.2200 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0648 -10.8135 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7762 -12.0372 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6787 -12.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1601 -12.8471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6791 -13.5096 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.9773 -12.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3862 -13.5544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9309 -11.4078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4778 -9.9921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7320 -11.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9843 -10.4649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4371 -9.8569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6342 -10.0305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3856 -10.8067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7837 -10.2951 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
5 4 1 0
5 6 2 0
6 1 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
12 5 1 0
13 12 2 0
14 13 1 0
4 14 1 0
13 15 1 0
15 16 1 0
12 17 1 0
8 18 1 1
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
20 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 343.41Molecular Weight (Monoisotopic): 343.0991AlogP: 3.51#Rotatable Bonds: 5Polar Surface Area: 95.34Molecular Species: ACIDHBA: 6HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.57CX Basic pKa: 3.58CX LogP: 3.43CX LogD: 0.93Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.66Np Likeness Score: -0.78
References 1. Szlávik Z, Ondi L, Csékei M, Paczal A, Szabó ZB, Radics G, Murray J, Davidson J, Chen I, Davis B, Hubbard RE, Pedder C, Dokurno P, Surgenor A, Smith J, Robertson A, LeToumelin-Braizat G, Cauquil N, Zarka M, Demarles D, Perron-Sierra F, Claperon A, Colland F, Geneste O, Kotschy A.. (2019) Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity., 62 (15): [PMID:31339316 ] [10.1021/acs.jmedchem.9b00134 ]